FDA Adverse Event Injury Summary report: N

EASYTRAK 3

MDR report key: 2781018 · Received October 10, 2012

Report

Report Number
2124215-2012-13185
Event Type
Injury
Date Received
October 10, 2012
Date of Event
September 27, 2012
Report Date
October 26, 2012
Manufacturer
CPI - DEL CARIBE
Product Code
OJX
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, VISUAL INSPECTION OF THE LEAD WAS PERFORMED. INSPECTION OF THE LEAD BODY AND ELECTRODE TIP FOUND NO ANOMALIES.LABORATORY TESTING DID NOT IDENTIFY ANY LEAD CHARACTERISTICS THAT WOULD HAVE RESULTED IN THE CLINICAL OBSERVATION OF DISLODGEMENT.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT ONE DAY POST IMPLANT OF THIS LEAD, THE LEAD WAS NOTED TO BE DISLODGED. A REVISION PROCEDURE WAS PERFORMED AND THE LEAD WAS EXPLANTED AND REPLACED. NO ADVERSE PATIENT EFFECTS WERE REPORTED DURING THE PROCEDURE.

Description of Event or Problem · 1

THE LEAD WAS RETURNED TO ALLOW FOR RELIABILITY ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 EASYTRAK 3 IMPLANTABLE LEAD OJX CPI - DEL CARIBE 4549

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R